Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Yazigi Solis, M
weight loss at target dose (trial data) ~15% (STEP 1) CV risk reduction labelled Yes (SELECT obesity + CVD) Format Prefilled pen India price (May 2026) 5,66016,400/month (Poviztra co-marketed: 3,9998,999/month) DCGI-approved Yes (20252026) Generic competition in India n/a (innovator) Generic semaglutide 9+ Indian manufacturers Active molecule Semaglutide Receptor activity GLP-1 Primary indication T2D &/or obesity (brand-dependent) Max maintenance dose 0.52.4 mg weekly Avg
Am J Physiol 279:R1449R1454 Bertsch T, McKeirnan K (2018) ITCA 650
Additionally, further refinement of the RL feedback mechanism will allow the model to dynamically adjust and improve during the generation process, increasing adaptability and output quality
US$ 24.62
US$ 27.01
US$ 24.59
US$ 22.00
US$ 25.81
US$ 25.43
US$ 21.07
US$ 29.82
US$ 22.80
US$ 26.09
US$ 20.96
